在胆固醇病的Farnesoid X受体介导胆酸调节中
Thamer Abdulla Mohammed1, Munaf H Zalzala2
1Ministry of Health and Environment, A State Company That Markets Drugs and Medical Appliances in Baghdad, Baghdad, Iraq.
Indian journal of clinical biochemistry : IJCB
|March 16, 2026
概括
华氏体X受体 (FXR) 调节胆汁酸 (BA) 代谢,影响葡萄糖和脂质平衡. 这项研究探讨了FXR.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 胆固醇的消除包括通过肝脏转化为胆汁酸 (BAs).
- 核受体Farnesoid X受体 (FXR) 对于调节BA,葡萄糖和脂质代谢至关重要.
- FXR在肝脏和肠道等关键代谢器官表达.
研究的目的:
- 调查FXR在调节胆酸代谢中的作用.
- 为了检查FXR在胆固醇病理生理学的参与.
主要方法:
- 对FXR结合部位和基因活动的分析.
- 调查FXR在胆酸平衡途径中的作用.
- 在胆固醇形成模型中探索FXR的功能.
主要成果:
- FXR通过刺激小异构体伴侣 (SHP) 和纤维细胞生长因子15/19 (FGF15/FGF19) 的表达来调节BA稳态.
- 激活FXR可以抑制肝脏BA合成酶细胞染色体P450 7A1 (Cyp7a1).
- FXR影响转录调节,自,亡和炎症.
结论:
- FXR是胆汁酸代谢和恒温的关键调节者.
- 在胆固醇形成的病理生理过程中,FXR起着重要的作用.
相关概念视频
Transducer Mechanism: Nuclear Receptors
4.8K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
4.8K
Hepatic Drug Excretion: Influencing Factors
706
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
706
Hepatic Drug Excretion: Enterohepatic Cycling
3.2K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.2K
Cholesterol: Significance and Regulation
1.8K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.8K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
313
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
313
Hepatic Drug Clearance: Role of Transporters
361
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
361


